Status | Study |
Recruiting |
Study Name: Active Surveillance, Bleomycin, Carboplatin, Etoposide, or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors Condition: Adult Germ Cell Tumor Childhood Extracranial Germ Cell Tumor Date: 2017-02-14 Interventions: Other: Best Practice Undergo o |
Recruiting |
Study Name: Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients With Relapsed or Refractory Germ Cell Tumors Condition: Germ Cell Tumor Teratoma Choriocarcinoma Date: 2015-02-20 Interventions: Drug: paclitaxel IV |
Recruiting |
Study Name: DNA Analysis in Samples From Younger Patients With Germ Cell Tumors and Their Parents or Siblings Condition: Childhood Malignant Ovarian Germ Cell Tumor Childhood Malignant Testicular Germ Cell Tumor Date: 2011-09-13 Interventions: Other: laboratory biomarker analysis |
Terminated |
Study Name: Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell Leukemia Condition: Childhood Atypical Teratoid/Rhabdoid Tumor Childhood Central Nervous System Choriocarcinoma Date: 2010-03-16 Interventions: Drug: gamma-secretase/Notch signalling pathway inhibitor RO4929097 |
Active, not recruiting |
Study Name: Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy Condition: Cognitive Side Effects of Cancer Therapy Malignant Ovarian Epithelial Tumor Date: 2010-03-03 Interventions: Procedure: Cognitive Assessment |
Completed |
Study Name: Vorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spinal Cord Tumors Condition: Childhood Atypical Teratoid/Rhabdoid Tumor Childhood Central Nervous System Choriocarcinoma Date: 2010-02-25 Interventions: Drug: vorinostat Other Names: |
Completed |
Study Name: Vorinostat and Bortezomib in Treating Young Patients With Refractory or Recurrent Solid Tumors, Including Central Nervous System Tumors and Lymphoma Condition: Childhood Burkitt Lymphoma Childhood Central Nervous System Choriocarcinoma Date: 2009-10-10 Interventions: Drug: vorinostat Given orally |
Completed |
Study Name: Pazopanib Hydrochloride in Treating Young Patients With Solid Tumors That Have Relapsed or Not Responded to Treatment Condition: Childhood Central Nervous System Choriocarcinoma Childhood Central Nervous System Embryonal Date: 2009-06-27 Interventions: Drug: pazopanib hydrochloride |
Completed |
Study Name: Combination Chemotherapy and Pegfilgrastim in Treating Patients With Previously Untreated Germ Cell Tumors Condition: Brain and Central Nervous System Tumors Extragonadal Germ Cell Tumor Date: 2007-05-03 Interventions: Biological: pegfilgrastim Drug: cisplatin |
Completed |
Study Name: Combination Chemotherapy in Treating Young Patients With Recurrent or Resistant Malignant Germ Cell Tumors Condition: Childhood Extracranial Germ Cell Tumor Childhood Extragonadal Germ Cell Tumor Date: 2007-04-25 Interventions: Drug: paclitaxel Given IV dosa |